IRF-1 Promotes Liver Transplant Ischemia/Reperfusion Injury via Hepatocyte IL-15/IL-15Rα Production
Shinichiro Yokota(Jichi Medical University), David A. Geller(University of Pittsburgh Medical Center), Kumiko Isse(University of Pittsburgh), Donna B. Stolz(University of Pittsburgh), Shoko Kimura(Harvard University), Angus W. Thomson(University of Pittsburgh), Lei Dou(University of Pittsburgh), Osamu Yoshida(Ehime University Hospital), Mark A. Ross(University of Kentucky), Qiang Du(Beijing Institute of Technology), Anthony V. Spadaro(University of Pittsburgh), Anthony J. Demetris(University of Pittsburgh Medical Center)
Cited by 46
Related Papers
The Banff 97 working classification of renal allograft pathology
|Kidney International|1999|3.1k
The International Position on Laparoscopic Liver Surgery
|Annals of Surgery|2009|1.5k
Antibody-Mediated Rejection Criteria - an Addition to the Banff ’97 Classification of Renal Allograft Rejection
|American Journal of Transplantation|2003|1.1k
The Banff 2019 Kidney Meeting Report (I): Updates on and clarification of criteria for T cell– and antibody-mediated rejection
|American Journal of Transplantation|2020|809